Patients undergoing major orthopedic surgery and trauma with Fondaparinux or low molecular weight heparin for VTE prevention
Conditions
Interventions
Fondaparinux Sodium Injection:VTE prevention
low molecular weight heparin:VTE prevention
Sponsors
Fuyang People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Major orthopedic surgery and trauma patients who have been treated with Fondaparinux Sodium Injection or low molecular weight heparin for deep vein thrombosis anticoagulation prevention; 2. Patients with complete inpatient information and complete follow-up information
Exclusion criteria
Exclusion criteria: 1. Patients taking Fondaparinux Sodium Injection or other anticoagulants other than LMWH during hospitalization; 2. Patients who underwent total hip total knee replacement =2 times during the study period; 3. Patients admitted with VTE diagnosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood routine;Clotting function test;VTE event;Bleeding events; | — |
Secondary
| Measure | Time frame |
|---|---|
| kidney function; | — |
Countries
China
Contacts
Public ContactDonglin Fu
Fuyang People's Hospital
Outcome results
None listed